Material Impact

While most of the venture capital industry spent the 2010s competing for the best SaaS metrics and the fastest consumer app growth curves, Material Impact was built around a different premise: that the most durable and defensible companies of the next generation would not be built in software alone, but at the boundary between software and the physical world — in materials, energy, manufacturing, robotics, and the advanced technologies that underpin every industry that software touches but does not displace. It was a contrarian position in 2016. By the mid-2020s, with the climate crisis, the defense technology renaissance, and the reindustrialization of the American economy driving institutional capital toward exactly those sectors, it looked like foresight.

Founded in Boston and backed by deep connections to the MIT and Harvard research ecosystems, Material Impact invests from seed through Series B in companies developing advanced materials, energy technology, robotics and manufacturing systems, climate solutions, and defense-adjacent technologies. The firm's partners bring backgrounds that span both the investment world and the physical sciences — a combination that is genuinely rare in venture capital and that allows Material Impact to evaluate technical claims with a rigor that generalist investors cannot apply, and to support founders navigating the gap between laboratory validation and commercial-scale manufacturing with the operational depth those transitions require.

Partner Ben Schlatka and his colleagues have built a portfolio that reads as a map of where the next decade of industrial technology is being written: companies developing novel battery chemistries, next-generation composite materials, autonomous manufacturing systems, and energy infrastructure components whose names will not appear on a consumer app store but whose impact will be measured in the decarbonization of industries that software alone cannot touch. For limited partners seeking exposure to the physical technology renaissance in its earliest and most defensible form, Material Impact's institutional track record in a category that most venture funds still treat as too hard is the specific advantage that patient capital deserves.